Project Grant H79TI084422
Award Date
9/30/21
Completion Date
9/29/26
Dollars Obligated
$7.4M
Funding Federal Agency
SAMHSA Center for Substance Abuse Treatment
Awarding Federal Agency
SAMHSA Division of Grants Management
Awardee
Howardcenter (TZKWLCHDDL45)
Federal Grant Program
93.243
Assistance Type
Project Grant
Place of Performance
Vermont, USA
Similar Awards
This $600,000 Project Grant award from the Health Resources and Services Administration (HRSA) under the Community Health Centers (CFDA 93.224) program will enable El Centro Family Health, a Federally Qualified Health Center (FQHC) in New Mexico, to establish a mobile, multi-disciplinary team to provide intensive Medication for Opioid Use Disorder (MOUD) treatment, counseling, and recovery services to hard-to-reach patients. This includes individuals involved in the justice system,...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $235,542 to Brigham & Women's Hospital Inc. to conduct a double-blind, randomized clinical trial evaluating the safety of using extended-release buprenorphine (XR-BUP) as a low-dose induction strategy for patients with opioid use disorder. The study aims to determine if XR-BUP can be safely administered before the emergence of opioid withdrawal...
This federal Project Grant award of $600,000 from the Health Resources and Services Administration's (HRSA) Community Health Centers (CFDA 93.224) program, awarded to Grace Community Health Center (doing business as Grace Health) on September 1, 2024, will be used to expand mental health and substance use disorder services, including medication for opioid use disorder (MOUD), in the rural Appalachian region of southeastern Kentucky. Specifically, the grant funding will enable Grace Health to...
The $1,600,000 Vermont First Responder Emergency Opioid Response Project is a Project Grant awarded by the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program. The project aims to enhance the ability of first responders and key community sectors in Vermont to safely provide emergency treatment for opioid overdoses, increase referrals to treatment and...
This federal Project Grant award from the Centers for Disease Control and Prevention's Injury Prevention and Control Research and State and Community Based Programs (CFDA 93.136) in the amount of $1,749,422.00 will fund a 3-year study at The General Hospital Corporation (Massachusetts General Hospital) to evaluate the role of telehealth in buprenorphine treatment initiation and retention, overdose mortality, and access equity. The award will support the research team in collaborating with Dr....
The Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program, administered by the Substance Abuse and Mental Health Services Administration (SAMHSA), awarded a $21,974,608 Project Grant to the Vermont Department of Health, Division of Substance Use Programs. The grant will support a comprehensive set of activities to increase access to opioid use disorder and stimulant use disorder treatment, increase regional capacity to implement...
This $600,000 Project Grant was awarded by the Health Resources and Services Administration (HRSA) under the Community Health Centers (CFDA 93.224) federal grant program. The award will fund West County Health Centers, Inc. to significantly expand access to medication-assisted treatment (MOUD) and substance use disorder/opioid use disorder (SUD/OUD) treatment, as well as provide increased mental health counseling services for the unsheltered population and youth/young adults in western Sonoma...
This Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) provides $844,475 to the University of Alabama at Birmingham (UAB) to test a bundled intervention aimed at increasing treatment uptake for patients with opioid use disorder (OUD) and nonfatal opioid overdoses after emergency department (ED) discharge. The proposed intervention combines telehealth, peer support, buprenorphine prescribing, and linkage to...
This $2,930,360 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) aims to evaluate the real-world effectiveness of telehealth-delivered buprenorphine (tele-buprenorphine) for treating opioid use disorder (OUD). The project will use a novel "emulated target trial" approach to analyze national data from the Veterans Health Administration and Medicaid to compare the effectiveness of tele-buprenorphine...
The federal Project Grant award of $850,000 from the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program will fund the establishment of a Mobile Montgomery County Recovery Center (Mobile MCRC) to serve uninsured and underinsured individuals with opioid use disorder (OUD) in Montgomery County, Pennsylvania. The grant recipient, Resources For Human Development,...